These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6356306)

  • 1. Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
    Moesgaard Nielsen V; Vinther B; Illum P
    Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.
    Horak F; Matthes H
    Ann Allergy; 1982 May; 48(5):305-8. PubMed ID: 7044195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB).
    Moesgaard-Nielsen V; Vinther B; Illum P; Harvig H
    Rhinology; 1986 Sep; 24(3):175-9. PubMed ID: 3534992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].
    Reckers R
    Arzneimittelforschung; 1977; 27(11a):2240-4. PubMed ID: 341901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
    Svensson G
    Rhinology; 1982 Sep; 20(3):159-66. PubMed ID: 6127780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical data of fluocortin butylester (FCB) - a new inhalable corticoid.
    Chen-Walden H
    Z Erkr Atmungsorgane; 1981; 157(3):287-90. PubMed ID: 7340214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerance of fluocortin butyl administered twice daily in adult patients with perennial rhinitis.
    Hartley TF; Lieberman PL; Meltzer EO; Noyes JN; Pearlman DS; Tinkelman DG
    J Allergy Clin Immunol; 1985 Apr; 75(4):501-7. PubMed ID: 3884690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
    Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR
    J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyposensitisation in grass pollen hay fever. A double blind trial of alumn precipitated pollen extract and depot emulsion pollen extract compared with placebo injections.
    McAllen MK
    Acta Allergol; 1969 Dec; 24(6):421-31. PubMed ID: 4910693
    [No Abstract]   [Full Text] [Related]  

  • 12. Pollen challenge study of a phototherapy device for reducing the symptoms of hay fever.
    Emberlin JC; Lewis RA
    Curr Med Res Opin; 2009 Jul; 25(7):1635-44. PubMed ID: 19476405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hay fever treatment with budesonide and beclomethasone dipropionate twice daily - a clinical comparison.
    Pipkorn U
    Rhinology; 1983 Dec; 21(4):335-40. PubMed ID: 6364297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center, double-blind, placebo-controlled trial of fluocortin butyl in perennial rhinitis.
    Arbesman C; Bernstein IL; Bierman CW; Bocles JS; Katz R; Lieberman PL; Mattucci K; Meltzer EO; Middleton E; Noyes J; Pearlman DS; Pence HL; Slavin RG; Spector SL
    J Allergy Clin Immunol; 1983 Jun; 71(6):597-603. PubMed ID: 6343462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide and beclomethasone dipropionate in hay fever - a single blind comparison.
    Pipkorn U; Rundcrantz H
    Eur J Respir Dis Suppl; 1982; 122():211-20. PubMed ID: 6958487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial.
    Tamura M; Shikina T; Morihana T; Hayama M; Kajimoto O; Sakamoto A; Kajimoto Y; Watanabe O; Nonaka C; Shida K; Nanno M
    Int Arch Allergy Immunol; 2007; 143(1):75-82. PubMed ID: 17199093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.